Biogena Group Invest AG (WBO:BIO) Debt-to-Revenue : 0.00 (As of Jan. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Biogena Group Invest AG Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Biogena Group Invest AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was €0.00 Mil. Biogena Group Invest AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was €0.00 Mil. Biogena Group Invest AG's annualized Revenue for the quarter that ended in Jan. 2024 was €0.17 Mil. Biogena Group Invest AG's annualized Debt-to-Revenue for the quarter that ended in Jan. 2024 was 0.00.

Biogena Group Invest AG Debt-to-Revenue Historical Data

The historical data trend for Biogena Group Invest AG's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biogena Group Invest AG Debt-to-Revenue Chart

Biogena Group Invest AG Annual Data

Trend

Jan21

Jan22

Jan23

Jan24

Debt-to-Revenue

Biogena Group Invest AG Semi-Annual Data
	Jan21	Jan22	Jan23	Jan24
Debt-to-Revenue	-	-	-	-

Competitive Comparison of Biogena Group Invest AG's Debt-to-Revenue

For the Packaged Foods subindustry, Biogena Group Invest AG's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biogena Group Invest AG's Debt-to-Revenue Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Biogena Group Invest AG's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Biogena Group Invest AG's Debt-to-Revenue falls into.

Biogena Group Invest AG Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Biogena Group Invest AG's Debt-to-Revenue for the fiscal year that ended in Jan. 2024 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0	+	0)	/	0.166
	=	0.00

Biogena Group Invest AG's annualized Debt-to-Revenue for the quarter that ended in Jan. 2024 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0	+	0)	/	0.166
	=	0.00

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is one times the quarterly (Jan. 2024) Revenue data.

Biogena Group Invest AG Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Biogena Group Invest AG's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Biogena Group Invest AG (WBO:BIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Biogena Group Invest AG (WBO:BIO) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Strubergasse 24, Salzburg, AUT, 5020

Website

https://www.biogenagroup.com

Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.